Linc

Linc Profit per Employee

The Profit per Employee of Linc (LINC.ST) as of Nov 20, 2026 is -199.82 M SEK. In the previous year, Profit per Employee was 650.80 M SEK — a change of -130.70% (lower).

Profit per Employee

-199.82 MSEK

YoY

-130.70%

Last updated:

Profit per Employee of Linc is 2025 -199.82 M SEK. Profit per Employee of Linc was 2024 650.80 M SEK. It decreases by -130.70% lower compared to the previous year.

The Linc Profit per Employee history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Profit per Employee
Date
Profit per Employee
Jan 1, 2018
157.96 M SEK
Jan 1, 2019
298.09 M SEK
Jan 1, 2020
416.59 M SEK
Jan 1, 2021
-15.01 M SEK
Jan 1, 2022
-361.67 M SEK
Jan 1, 2023
309.73 M SEK
Jan 1, 2024
650.80 M SEK
Jan 1, 2025
-199.82 M SEK
The Linc Profit per Employee history
YEARProfit per EmployeeYoY
-199.82 MSEK-130.70%
650.80 MSEK+110.12%
309.73 MSEK-185.64%
-361.67 MSEK+2,308.79%
-15.01 MSEK-103.60%
416.59 MSEK+39.75%
298.09 MSEK+88.71%
157.96 MSEK—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Linc Stock analysis

What does Linc do? Linc AB generates revenue through long-term share ownership in Nordic life science companies, focusing on pharmaceutical and medical technology sectors. The company invests in both private and public firms, including early-stage drug development and operational medical technology companies. Linc Invest actively supports portfolio companies by collaborating with management, founders, and boards to unlock growth potential and drive expansion. Its industrial network enables strategic participation in nomination committees and development planning. The firm targets Nordic life science product-oriented companies, prioritizing pharmaceuticals and medical technology. Investments span research and operational phases, with drug development typically occurring earlier than in medical technology. Linc AB maintains a hands-on approach as a long-term owner, leveraging its network to assist portfolio companies in achieving ambitious development goals. Linc AB's business model centers on active ownership and strategic partnerships within the Nordic life science ecosystem. It focuses on companies with strong product pipelines, particularly in pharmaceuticals, where investments often occur during initial development stages. The company's role as a supportive shareholder drives value creation through collaborative governance and targeted expansion strategies. Linc is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Linc stock

Profit per Employee of Linc is -199.82 M SEK in 2025.

Profit per Employee of Linc changed from 650.80 M SEK to -199.82 M SEK, representing a -130.70% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Profit per Employee Linc since 2006 – with annual values, charts, and detailed analysis.

Profit per employee measures how much net income each employee generates on average. It is a key indicator of workforce efficiency.

Profit per Employee's SEK is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Profit per Employee's Linc historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Workforce — Linc

All Key Metrics — Linc